{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "20461736",
  "DateCompleted": {
    "Year": "2010",
    "Month": "08",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/emmm.201000071"
    ],
    "Journal": {
      "ISSN": "1757-4684",
      "JournalIssue": {
        "Volume": "2",
        "Issue": "5",
        "PubDate": {
          "Year": "2010",
          "Month": "May"
        }
      },
      "Title": "EMBO molecular medicine",
      "ISOAbbreviation": "EMBO Mol Med"
    },
    "ArticleTitle": "Mutations for the people.",
    "Pagination": {
      "StartPage": "143",
      "EndPage": "145",
      "MedlinePgn": "143-5"
    },
    "Abstract": {
      "AbstractText": [
        "Similar cancer types may nevertheless differ widely in the genetic mutations they carry. In this Closeup, Kristensen and Borresen-Dale discuss how identifying these mutations can define which therapy is most likely to succeed in eliminating the cancerous cells and how the methodology developed by Dias-Santagata et al and described in this issue, is an important step in making mutation screening a reality in the clinical practice worldwide."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute for Cancer Research, Oslo, Norway. v.n.kristensen@medisin.uio.no"
          }
        ],
        "LastName": "Kristensen",
        "ForeName": "Vessela",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Borresen-Dale",
        "ForeName": "Anne-Lise",
        "Initials": "AL"
      }
    ],
    "PublicationTypeList": [
      "Comment",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "EMBO Mol Med",
    "NlmUniqueID": "101487380",
    "ISSNLinking": "1757-4676"
  },
  "CommentsCorrectionsList": [
    {
      "RefSource": "EMBO Mol Med. 2010 May;2(5):146-58",
      "PMID": "20432502"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "DNA Mutational Analysis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genotype"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [
        "genetics",
        "therapy"
      ],
      "DescriptorName": "Neoplasms"
    }
  ]
}